Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
IKK16
IKK
NFKB
10520.1
uM
2.40510
2.88530
-0.7137 -0.7142 4.8747 0.4327
0.9970
3.6151
SUM159PT
TNBC
Basal B
IKK16
IKK
NFKB
7531.093
uM
1.40610
2.10440
-0.7611 -0.7731 2.3179 0.4823
0.9996
3.5995
SUM159PT
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7531.091
uM
16.48580
19.68790
-0.7788 -0.7146 5.0000 0.4358
0.9967
3.3140
SUM159PT
TNBC
Basal B
Ispinesib
KSP
Kinesin
7531.067
uM
0.14051
1.2530
-0.7605 -1.0000 0.5021 0.5563
0.9445
3.6061
SUM159PT
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7531.095
uM
0.01770
0.35537
-0.7677 -1.0000 0.3663 0.7622
0.9140
3.5302
SUM159PT
TNBC
Basal B
JNK-IN-5A
JNK
JNK
11057.144
uM
14.15840
170.79050
-0.1209 -1.0000 0.4412 0.2119
0.8005
3.7784
SUM159PT
TNBC
Basal B
L-779450
BRAF
MAPK
10520.137
uM
18.60730
49.81870
0.2133 -1.0000 1.1155 0.1476
0.8304
3.7823
SUM159PT
TNBC
Basal B
L-779450
BRAF
MAPK
11057.149
uM
29.35970
49.41790
0.4099 -0.8250 1.8716 0.0368
0.9824
4.1019
SUM159PT
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7531.098
uM
inf
inf
0.9783 0.9783 0.0000 -0.0040
0.0169
3.4793
SUM159PT
TNBC
Basal B
LBH589
HDAC
HDAC
11057.154
uM
0.24013
0.40952
-0.7352 -0.7529 1.7208 0.6122
0.9965
3.8498
SUM159PT
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10520.142
uM
0.60192
4.63920
-0.7591 -1.0000 0.5380 0.5173
0.9805
3.1766
SUM159PT
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11057.154
uM
0.93514
4.6160
-0.7352 -1.0000 0.6881 0.3694
0.9808
3.8498
SUM159PT
TNBC
Basal B
Mebendazole
13054.174
uM
0.26419
0.20965
0.0726 0.1958 2.1487 0.3901
0.9341
3.1161
SUM159PT
TNBC
Basal B
Mebendazole
13004.174
uM
0.25791
0.33026
-0.1743 -0.1821 1.2558 0.5096
0.9921
3.2757
SUM159PT
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7531.085
uM
inf
inf
0.9657 0.9657 0.0000 0.0219
0.4445
3.5188
SUM159PT
TNBC
Basal B
Methylglyoxal
13054.184
uM
220.47610
301.56480
-0.8767 -0.7403 2.9008 0.8005
0.8788
2.8248
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14287.189
uM
0.06674
0.07631
-0.9166 -0.4766 5.0000 0.8754
0.6679
2.3947
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14287.189
uM
0.06674
0.07631
-0.9166 -0.4766 5.0000 0.8754
0.6679
2.3947
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14176.189
uM
0.07247
0.0870
-1.0000 -0.7475 5.0000 0.9511
0.8952
0.4285
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14176.189
uM
0.07247
0.0870
-1.0000 -0.7475 5.0000 0.9511
0.8952
0.4285
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
11057.145
uM
0.05731
0.07460
-0.7373 -0.5011 2.6315 0.7726
0.9669
3.8266
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
11057.145
uM
0.05731
0.07460
-0.7373 -0.5011 2.6315 0.7726
0.9669
3.8266
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14625.189
uM
0.04393
0.06589
-0.8973 -0.8783 2.5014 1.0556
0.9734
2.7202
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
14625.189
uM
0.04393
0.06589
-0.8973 -0.8783 2.5014 1.0556
0.9734
2.7202
SUM159PT
TNBC
Basal B
Pevonedistat
NAE1
NAE1
10520.135
uM
0.79624
0.86326
-0.0471 -0.0481 1.1374 0.3389
0.9955
3.6895